3-Methyl-4-oxo-4,5,6,7-tetrahydro-benzofuran-2-carboxylic acid methyl ester, 95.0%, 500mg

2,4-Diamino-5-methyl-6-quinazolinecarbonitrile, 98%, 1g

1,2,4,5-Tetrakis(tert-butylthio)benzene>98.0%(GC)1g

2-Bromo-N,N-dimethylthiazole-5-carboxamide, 98%, 250mg

iScope IS.1153-PLi/DFi Triocular with Plan IOS objectives and Rackless cross stage (dark field contrast application)

1-(4-Chloro-phenyl)-1H-pyrazole-4-carbaldehyde, 95.0%, 10g

2-Fluoro-3-iodo-5-methylpyridine, 97.0%, 10g

Ethyl (1R,2R)-2'-oxospiro[cyclopropane-1,3'-indoline]-2-carboxylate, 98%, 1g

Silicone oil PN 1000, 1 kg

1-Methyl-1-propylpyrrolidin-1-ium Bromide>98.0%(T)5g

(R)-2-Hydroxy-4-methylpentanoic acid, 95.0%, 100g

Methyl (1s,3s)-3-amino-1-methylcyclobutane-1-carboxylate hydrochloride, 98%, 100mg

4,4'-Di(1H-1,2,4-triazol-1-yl)-1,1'-biphenyl, 95%, 250mg